Two-thirds (66%) of the respondents to the MHE survey said they expect Prescription Drug User Fee Act (PDUFA) dates to be ...

The FDA has granted Mesoblast’s stem cell therapy, Ryoncil (remestemcel-L), seven years of orphan drug exclusivity for the ...

Eric Tichy, Pharm.D., M.B.A., vice chair of pharmacy formulary at the Mayo Clinic Health System, explains potential ...

Men and people ages 45 and older face additional risk of serious kidney conditions six to 12 months after their viral illness ...

Bayer’s Jivi is a factor VIII replacement therapy that has been engineered with a compound that allows for less frequent dosing. It is now indicated for patients 7 years of age and older.